A Study to Evaluate Denosumab in Young Patients With Primary Breast Cancer (D-Beyond)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01864798
Recruitment Status : Terminated (Poor recruitment)
First Posted : May 30, 2013
Last Update Posted : September 5, 2017
Melbourne Health
Information provided by (Responsible Party):
Jules Bordet Institute

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : December 2017
  Estimated Study Completion Date : December 2017